Postoperative Management for HNSCC Based on Pathological Response of Induction Chemotherapy and Immunotherapy

To develop postoperative stratification treatment for patients who have received induction chemotherapy and immunotherapy in locally advanced head and neck cancers. Risk stratification is based on clinical characteristics and pathological responses. In order to achieve no inferior survival rate and a lower treatment-related toxicity rate than the standard treatment.

Trial Details

NCT ID
NCT05777824
Phase
PHASE2
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • anti-PD-1 or PD-L1 antibody
  • postoperative radiaotherapy
Locations (sample)
  • Beijin, Beijing Municipality, China

Key Eligibility Criteria

  • The subjects are not limited by gender, age from 18 to 75 years old;
  • Histopathologically confirmed squamous cell carcinoma of the head and neck cancer;
  • Locally advanced squamous cell carcinoma diagnosed as T3-4 or N+ stage according to AJCC 8th edition staging;
  • ECOG score 0-1;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →